These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12173844)

  • 41. Impact of Time Interval Between Glenn and Fontan Procedures on Fontan Operative and Long-Term Follow-up Results.
    Yi T; Fan G; Xing Y; Zhao W; Zhang L; Fan F; Jiang X; Ma Z; Yan J; Li S; Wang Q
    Pediatr Cardiol; 2019 Apr; 40(4):705-712. PubMed ID: 30652193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombotic and Embolic Complications Associated With Atrial Arrhythmia After Fontan Operation: Role of Prophylactic Therapy.
    Egbe AC; Connolly HM; McLeod CJ; Ammash NM; Niaz T; Yogeswaran V; Poterucha JT; Qureshi MY; Driscoll DJ
    J Am Coll Cardiol; 2016 Sep; 68(12):1312-9. PubMed ID: 27634123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coagulation and Anticoagulation in Fontan Patients.
    Heidendael JF; Engele LJ; Bouma BJ; Dipchand AI; Thorne SA; McCrindle BW; Mulder BJM
    Can J Cardiol; 2022 Jul; 38(7):1024-1035. PubMed ID: 35122939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does pregnancy impact subsequent health outcomes in the maternal Fontan circulation?
    Moroney E; Zannino D; Cordina R; Gentles T; d'Udekem Y; Zentner D
    Int J Cardiol; 2020 Feb; 301():67-73. PubMed ID: 31575496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased P-selectin expression on platelets and decreased plasma thrombomodulin in Fontan patients.
    Kajimoto H; Nakazawa M; Murasaki K; Hagiwara N; Nakanishi T
    Circ J; 2009 Sep; 73(9):1705-10. PubMed ID: 19638712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic oxygen saturation and coagulation factor abnormalities before and after the fontan procedure.
    Cheung EW; Chay GW; Ma ES; Cheung YF
    Am J Cardiol; 2005 Dec; 96(11):1571-5. PubMed ID: 16310443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bidirectional cavopulmonary shunt with additional pulmonary blood flow: a failed or successful strategy?
    Gérelli S; Boulitrop C; Van Steenberghe M; Maldonado D; Bojan M; Raisky O; Sidi D; Vouhé PR
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):513-9. PubMed ID: 22368190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thromboembolic complications in Fontan patients: population-based prevalence and exploration of the etiology.
    Idorn L; Jensen AS; Juul K; Reimers JI; Johansson PI; Sørensen KE; Ostrowski SR; Søndergaard L
    Pediatr Cardiol; 2013 Feb; 34(2):262-72. PubMed ID: 22843202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conversion of atriopulmonary or lateral atrial tunnel cavopulmonary anastomosis to extracardiac conduit Fontan modification.
    van Son JA; Mohr FW; Hambsch J; Schneider P; Hess H; Haas GS
    Eur J Cardiothorac Surg; 1999 Feb; 15(2):150-7; discussion 157-8. PubMed ID: 10219547
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcomes of Fontan conversion for failing Fontan circulation: mid-term results.
    Park HK; Shin HJ; Park YH
    Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):14-7. PubMed ID: 27001674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Congenital cardiopathy: indications for anticoagulant treatment].
    Losay J; Touchot-Koné A; Lambert V
    Arch Mal Coeur Vaiss; 2005 May; 98(5):566-70. PubMed ID: 15966610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk of thromboembolic complications in adult congenital heart disease: A literature review.
    Karsenty C; Zhao A; Marijon E; Ladouceur M
    Arch Cardiovasc Dis; 2018 Oct; 111(10):613-620. PubMed ID: 29859704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time in therapeutic range as a marker for thrombotic and bleeding outcomes in Fontan patients.
    Faircloth JM; Miner KM; Alsaied T; Nelson N; Ciambarella J; Mizuno T; Palumbo JS; Vinks AA; Veldtman GR
    J Thromb Thrombolysis; 2017 Jul; 44(1):38-47. PubMed ID: 28429248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Bilateral Bidirectional Glenn Operation as a Risk Factor Prior to Fontan Completion in Complex Congenital Heart Disease Patients.
    Keizman E; Tejman-Yarden S; Mishali D; Levine S; Borik S; Pollak U; Katz U; Serraf AE
    World J Pediatr Congenit Heart Surg; 2019 Mar; 10(2):174-181. PubMed ID: 30841839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early and medium-term results after modified Fontan operation in adults.
    Ovroutski S; Alexi-Meskishvili V; Ewert P; Nürnberg JH; Hetzer R; Lange PE
    Eur J Cardiothorac Surg; 2003 Mar; 23(3):311-6. PubMed ID: 12614799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The modified Fontan procedure with use of extracardiac conduit in adults: analysis of 32 consecutive patients.
    Ly M; Roubertie F; Kasdi R; Chatti S; Vergnat M; Luu D; Le Bret E; Roussin R; Capderou A; Belli E
    Ann Thorac Surg; 2014 Dec; 98(6):2181-6. PubMed ID: 25443023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Results of Fontan operation in patients with atrioventricular valve regurgitation.
    Podzolkov VP; Chiaureli MR; Yurlov IA; Zelenikin MM; Kovalev DV; Dontsova VI; Astrakhantseva TO; Putiato NA; Zaets SB
    Eur J Cardiothorac Surg; 2015 Aug; 48(2):308-14; discussion 314-5. PubMed ID: 25527172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fontan palliation in the modern era: factors impacting mortality and morbidity.
    Tweddell JS; Nersesian M; Mussatto KA; Nugent M; Simpson P; Mitchell ME; Ghanayem NS; Pelech AN; Marla R; Hoffman GM
    Ann Thorac Surg; 2009 Oct; 88(4):1291-9. PubMed ID: 19766824
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Revision of previous Fontan connections to extracardiac or intraatrial conduit cavopulmonary anastomosis.
    McElhinney DB; Reddy VM; Moore P; Hanley FL
    Ann Thorac Surg; 1996 Nov; 62(5):1276-82; discussion 1283. PubMed ID: 8893557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure.
    McCrindle BW; Manlhiot C; Cochrane A; Roberts R; Hughes M; Szechtman B; Weintraub R; Andrew M; Monagle P;
    J Am Coll Cardiol; 2013 Jan; 61(3):346-53. PubMed ID: 23246393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.